At NINGBO INNO PHARMCHEM CO.,LTD., we recognize the profound impact of advanced chemical intermediates on medical breakthroughs. 3,5-Dimethylpyrrole-2,4-dicarboxylic Acid 2-t-Butyl Ester-4-Ethyl Ester, identified by CAS 86770-31-2, stands out as a pivotal component in the synthesis of Sunitinib. Sunitinib, a multi-targeted receptor tyrosine kinase inhibitor, has revolutionized the treatment of certain cancers, including renal cell carcinoma and gastrointestinal stromal tumors.

The journey from basic chemical compounds to life-saving pharmaceuticals is complex, and intermediates like this pyrrole derivative are essential linchpins. The structural integrity and high purity (≥99%) of 3,5-Dimethylpyrrole-2,4-dicarboxylic Acid 2-t-Butyl Ester-4-Ethyl Ester are critical for enabling the precise chemical transformations required to produce Sunitinib. Its role as a Sunitinib synthesis intermediate cannot be overstated; it provides the fundamental scaffold upon which the active pharmaceutical ingredient is built.

The demand for such intermediates directly correlates with advancements in oncology. As research uncovers new therapeutic targets and refines existing treatments, the need for reliable suppliers of high-quality chemicals increases. NINGBO INNO PHARMCHEM CO.,LTD. is committed to meeting this demand, ensuring that the supply chain for critical cancer therapies remains robust. The importance of consistent API intermediate supply is a cornerstone of our operations.

The chemical properties of this compound, including its molecular formula C14H21NO4 and molecular weight of 267.32, are carefully documented and controlled. These specifications, along with its physical characteristics such as its off-white powder appearance, are vital for process validation and quality assurance in pharmaceutical manufacturing. Understanding the precise nature of the CAS 86770-31-2 intermediate is fundamental for chemists and manufacturers.

Furthermore, the manufacturing expertise behind this compound, often originating from leading Chinese chemical manufacturers, ensures that it meets the rigorous standards demanded by the pharmaceutical industry. This focus on quality control throughout the pharmaceutical intermediate production process is what allows for the development of safer and more effective drugs.

In essence, 3,5-Dimethylpyrrole-2,4-dicarboxylic Acid 2-t-Butyl Ester-4-Ethyl Ester is more than just a chemical; it is an enabler of modern cancer treatments. NINGBO INNO PHARMCHEM CO.,LTD. is proud to contribute to this vital sector by providing essential, high-quality pharmaceutical intermediates that empower the development of therapies impacting lives worldwide.